Cargando…

Serum proteomic profiles of depressive subtypes

Depression is a highly heterogeneous disorder. Accumulating evidence suggests biological and genetic differences between subtypes of depression that are homogeneous in symptom presentation. We aimed to evaluate differences in serum protein profiles between persons with atypical and melancholic depre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamers, F, Bot, M, Jansen, R, Chan, M K, Cooper, J D, Bahn, S, Penninx, B W J H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545705/ https://www.ncbi.nlm.nih.gov/pubmed/27404283 http://dx.doi.org/10.1038/tp.2016.115

Ejemplares similares

Serum proteomic profiling of major depressive disorder
por: Bot, M, et al.
Publicado: (2015)

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)
por: Ramsey, Jordan M., et al.
Publicado: (2016)

Dissection of depression heterogeneity using proteomic clusters
por: van Haeringen, Marije, et al.
Publicado: (2023)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals
por: Han, Sung Yeon Sarah, et al.
Publicado: (2019)

Effects of dietary interventions on depressive symptom profiles: results from the MooDFOOD depression prevention study
por: Vreijling, Sarah R., et al.
Publicado: (2022)

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
por: Penninx, Brenda WJH, et al.
Publicado: (2013)

Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
por: Ramsey, Jordan M., et al.
Publicado: (2016)

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study
por: Beijers, Lian, et al.
Publicado: (2019)

Cytokine production capacity in depression and anxiety
por: Vogelzangs, N, et al.
Publicado: (2016)

Metabolomics signatures of depression: the role of symptom profiles
por: de Kluiver, Hilde, et al.
Publicado: (2023)

The similarity of the structure of DSM-IV criteria for major depression in depressed women from China, the United States and Europe
por: Kendler, K. S., et al.
Publicado: (2015)

The role of proteomics in depression research
por: Martins-de-Souza, Daniel, et al.
Publicado: (2009)

Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression
por: Kittel-Schneider, Sarah, et al.
Publicado: (2020)

Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults
por: Diniz, Breno S., et al.
Publicado: (2019)

Serum Proteomic Profiling of Obsessive-Compulsive Disorder, Washing Subtype: A Preliminary Study
por: Zamanian-Azodi, Mona, et al.
Publicado: (2017)

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
por: Martins-de-Souza, D, et al.
Publicado: (2012)

Association of food groups with depression and anxiety disorders
por: Gibson-Smith, Deborah, et al.
Publicado: (2019)

BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE
por: Hiles, Sarah A., et al.
Publicado: (2016)

The role of depressive symptoms and symptom dimensions in actigraphy-assessed sleep, circadian rhythm, and physical activity
por: Difrancesco, Sonia, et al.
Publicado: (2022)

Association Between Depression, Anxiety, and Antidepressant Use With T-Wave Amplitude and QT-Interval
por: Hu, Mandy X., et al.
Publicado: (2018)

Supplementation‐induced increase in circulating omega‐3 serum levels is not associated with a reduction in depressive symptoms: Results from the MooDFOOD depression prevention trial
por: Thesing, Carisha S., et al.
Publicado: (2020)

Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome
por: Steeb, Hannah, et al.
Publicado: (2014)

Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol
por: Bezstarosti, Karel, et al.
Publicado: (2006)

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
por: Zwiep, J.C., et al.
Publicado: (2022)

Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study
por: Black, C N, et al.
Publicado: (2016)

The role of anxious distress in immune dysregulation in patients with major depressive disorder
por: Gaspersz, Roxanne, et al.
Publicado: (2017)

The predictive value of Approach and Avoidance tendencies on the onset and course of depression and anxiety disorders
por: Struijs, Sascha Y., et al.
Publicado: (2018)

Retracted: Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol
por: Bezstarosti, Karel, et al.
Publicado: (2012)

The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder
por: Matcham, F., et al.
Publicado: (2023)

Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
por: de Kluiver, Hilde, et al.
Publicado: (2019)

Within‐day bidirectional associations between physical activity and affect: A real‐time ambulatory study in persons with and without depressive and anxiety disorders
por: Difrancesco, Sonia, et al.
Publicado: (2022)

Serum Proteomic Study of Women With Obsessive-Compulsive Disorder, Washing Subtype
por: Zamanian-Azodi, Mona, et al.
Publicado: (2018)

Affect fluctuations examined with ecological momentary assessment in patients with current or remitted depression and anxiety disorders
por: Schoevers, R. A., et al.
Publicado: (2021)

In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas
por: Kim, Jung Hee, et al.
Publicado: (2021)

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
por: Huang, Jeffrey T.-J., et al.
Publicado: (2007)

Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
por: Rontogianni, Stamatia, et al.
Publicado: (2019)

Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

Correction: Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

Serum N-glycan profiles differ for various breast cancer subtypes
por: Vreeker, Gerda C. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sj96uqo5qb6i913e26fjt844rr